CRDL logo

Cardiol Therapeutics (CRDL)

Profile

Full Name

Cardiol Therapeutics Inc.

Ticker Symbol

NASDAQ: CRDL

Exchange

NASDAQ

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Country

Canada

IPO

January 15, 2019

Indexes

Not included

Website

http://www.cardiolrx.com

Employees

18

Key Details

Price

$1.54(+10.79%)

Market cap

$127.28M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

-

Annual EPS

-$0.37(-14.15% YoY)

PE ratio

-

Next earnings date

Aug 12, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $1.54
    CRDL price is $1.54

    30-Day Relative Volume

    1.58
    CRDL 30-day relative volume is 1.58

    Price Performance

    Price Most recent change

    +10.79%
    CRDL price was up +10.79% on Jul 3, 2025

    Price YTD change

    +20.31%
    CRDL price is up +20.31% since January 1st

    Price 1-year change

    -19.79%
    CRDL price is down -19.79% year-on-year

    Price 3-year change

    +14.93%
    CRDL price is up +14.93% over the past 3 years

    Price Range

    Price All-time high

    $10.00
    CRDL price is currently -84.60% below its historical high of $10.00

    Price 3-year low

    $0.45
    CRDL price is currently +242.22% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $127.28M
    CRDL market capitalization is $127.28 million

    Market cap 3-year change

    +53.35%
    CRDL market capitalization is up +53.35% over the past 3 years

    Market cap All-time high

    $213.88M
    CRDL market capitalization is currently -40.49% below its historical high of $213.88 million

    Market cap sector rank

    47.25%
    CRDL market capitalization is higher than 47.25% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +19.22%
    CRDL shares outstanding is up +19.22% year-on-year

    Shares Outstanding 3-Year Change

    +33.44%
    CRDL shares outstanding is up +33.44% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    1.38
    CRDL beta is 1.38

    200-day SMA

    $1.41
    CRDL price is currently +9.24% above its 200-day simple moving average

    50-day SMA

    $1.25
    CRDL price is currently +23.52% above its 50-day simple moving average

    RSI

    63.32
    CRDL 14-day relative strength index is 63.32

    Volume

    1.58
    CRDL 30-day relative volume is 1.58

    ATR

    $0.10
    CRDL average true range is $0.10

    10-day Historical Volatility

    90.43%
    CRDL 10-day historical volatility is 90.43%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    -
    CRDL annual revenue value is unknown

    Revenue Analysts estimate

    -
    CRDL annual revenue consensus analysts' forecast is unknown

    Revenue 1-year change

    -
    CRDL annual revenue 1-year change is unknown

    Revenue Sector rank

    -
    CRDL annual revenue is unknown

    EPS

    EPS

    -$0.37
    CRDL annual earnings per share is -$0.37

    EPS Analysts estimate

    -$0.50
    CRDL annual earnings per share is currently -25.60% lower than the consensus analysts' forecast

    EPS 1-year change

    -14.15%
    CRDL annual earnings per share is down -14.15% year-on-year

    EPS Sector rank

    70.98%
    CRDL annual earnings per share is higher than 70.98% of companies in Healthcare sector

    Profit

    Gross profit

    -
    CRDL annual gross profit value is unknown

    Gross margin

    -
    CRDL annual gross profit margin value is unknown

    Operating profit

    -$29.38M
    CRDL annual operating income is -$29.38 million

    Operating margin

    -
    CRDL annual operating profit margin value is unknown

    Net income

    -$26.76M
    CRDL annual net profit is -$26.76 million

    Net margin

    -
    CRDL annual net profit margin value is unknown

    Expenses

    Total expenses

    $29.38M
    CRDL annual total expenses is $29.38 million

    Operating expenses

    $29.38M
    CRDL annual total operating expenses is $29.38 million

    Cost of goods sold

    -
    CRDL annual cost of goods sold value is unknown

    Selling, general & administrative expenses

    $19.16M
    CRDL annual SGA is $19.16 million

    Depreciation and amortization

    $272.20K
    CRDL annual depreciation & amortization is $272.20 thousand

    Interest expense

    -
    CRDL annual interest expense value is unknown

    Income tax

    -
    CRDL annual income tax value is unknown

    EBIT & EBITDA

    EBIT

    -$29.38M
    CRDL annual earnings before interest & taxes is -$29.38 million

    EBITDA

    -$29.11M
    CRDL annual EBITDA is -$29.11 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $22.20M
    CRDL annual total assets is $22.20 million

    Non current assets

    $136.30K
    CRDL annual long term assets is $136.30 thousand

    Current assets

    $22.07M
    CRDL annual total current assets is $22.07 million

    Cash and cash equivalents

    $21.31M
    CRDL annual cash & cash equivalents is $21.31 million

    Accounts receivable

    $69.90K
    CRDL annual accounts receivable is $69.90 thousand

    Inventory

    -
    CRDL annual inventory value is unknown

    Liabilities

    Total liabilities

    $4.97M
    CRDL annual total liabilities is $4.97 million

    Long term liabilities

    $87.50K
    CRDL annual total long term liabilities is $87.50 thousand

    Current liabilities

    $4.88M
    CRDL annual total current liabilities is $4.88 million

    Accounts payable

    -
    CRDL annual accounts payable value is unknown

    Debt

    Total debt

    $110.50K
    CRDL annual total debt is $110.50 thousand

    Total debt 1-year change

    -15.91%
    CRDL annual total debt is down -15.91% year-on-year

    Long term debt

    $87.50K
    CRDL annual long term debt is $87.50 thousand

    Short term debt

    $23.00K
    CRDL annual short term debt is $23.00 thousand

    Equity & Capital

    Shareholders equity

    $17.23M
    CRDL annual stockholders equity is $17.23 million

    Book value

    $17.23M
    CRDL annual book value is $17.23 million

    Retained earnings

    -$124.90M
    CRDL annual retained earnings is -$124.90 million

    Working capital

    $17.18M
    CRDL annual working capital is $17.18 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$18.28M
    CRDL annual cash flow from operations is -$18.28 million

    Cash from operations 1-year change

    +1.97%
    CRDL annual cash flow from operations is up +1.97% year-on-year

    Cash from investing

    -$15.50K
    CRDL annual cash flow from investing activities is -$15.50 thousand

    Cash from investing 1-year change

    +67.44%
    CRDL annual cash flow from investing activities is up +67.44% year-on-year

    Cash from financing

    $13.74M
    CRDL annual cash flow from financing activities is $13.74 million

    Cash from financing 1-year change

    +33621.95%
    CRDL annual cash flow from financing activities is up +33621.95% year-on-year

    CAPEX

    CAPEX

    -
    CRDL annual capital expenditures value is unknown

    CAPEX 1-year change

    -
    CRDL annual capital expenditures 1-year change is unknown

    Free Cash Flow

    Free cash flow

    -$18.30M
    CRDL annual free cash flow is -$18.30 million

    Free cash flow 1-year change

    +2.13%
    CRDL annual free cash flow is up +2.13% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    -
    CRDL annual gross profit margin value is unknown

    Operating margin

    -
    CRDL annual operating profit margin value is unknown

    Net margin

    -
    CRDL annual net profit margin value is unknown

    ROA & ROE

    ROA

    -120.51%
    CRDL annual return on assets is -120.51%

    ROE

    -155.29%
    CRDL annual return on equity is -155.29%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    CRDL price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    CRDL price to earnings ratio is unknown

    PB Ratio

    PB ratio

    10.36
    CRDL price to book ratio is 10.36

    PB ratio Sector rank

    90.39%
    CRDL price to book ratio is higher than 90.39% of companies in Healthcare sector

    PS Ratio

    PS ratio

    -
    CRDL price to sales ratio value is unknown

    PS ratio Sector rank

    -
    CRDL price to sales ratio is unknown

    Enterprise value

    Enterprise value

    $111.11M
    CRDL enterprise value is $111.11 million

    Enterprise value Sector rank

    47.06%
    CRDL enterprise value is higher than 47.06% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -3.86
    CRDL EV/EBITDA is -3.86

    EV/EBITDA Sector rank

    27.16%
    CRDL EV/EBITDA is higher than 27.16% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    4.52
    CRDL annual current ratio is 4.52

    Quick ratio

    -
    CRDL annual quick ratio value is unknown

    Leverage

    Debt to equity

    0.01
    CRDL annual debt to equity ratio is 0.01

    Interest coverage ratio

    -
    CRDL annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    -
    CRDL piotroski f-score value is unknown

    Altman Z-Score

    -
    CRDL altman z-score value is unknown

    Analyst ratings

    Recent major analysts updates

    Jun 2, 25 HC Wainwright & Co.
    Buy
    Apr 16, 25 HC Wainwright & Co.
    Buy
    Apr 7, 25 HC Wainwright & Co.
    Buy
    Feb 24, 25 HC Wainwright & Co.
    Buy
    Dec 18, 24 HC Wainwright & Co.
    Buy
    Nov 20, 24 HC Wainwright & Co.
    Buy
    Oct 24, 24 HC Wainwright & Co.
    Buy
    Jun 26, 24 Roth MKM
    Buy
    Jun 14, 24 HC Wainwright & Co.
    Buy
    Jun 7, 24 HC Wainwright & Co.
    Buy

    Institutional Ownership

    Screeners with CRDL included

    Growing Shares Outstanding
    Stocks with high beta
    Best performing stocks last month
    Best performing stocks last 3 months
    NASDAQ Dividend Calendar
    Canadian stocks
    Stocks above SMA 50
    Healthcare sector
    All stocks
    NASDAQ Listed Companies
    • What is the ticker symbol for Cardiol Therapeutics?
    • Does Cardiol Therapeutics pay dividends?
    • What sector is Cardiol Therapeutics in?
    • What industry is Cardiol Therapeutics in?
    • What country is Cardiol Therapeutics based in?
    • When did Cardiol Therapeutics go public?
    • Is Cardiol Therapeutics in the S&P 500?
    • Is Cardiol Therapeutics in the NASDAQ 100?
    • Is Cardiol Therapeutics in the Dow Jones?
    • When was Cardiol Therapeutics's last earnings report?
    • When does Cardiol Therapeutics report earnings?

    What is the ticker symbol for Cardiol Therapeutics?

    The ticker symbol for Cardiol Therapeutics is NASDAQ:CRDL

    Does Cardiol Therapeutics pay dividends?

    No, Cardiol Therapeutics does not pay dividends

    What sector is Cardiol Therapeutics in?

    Cardiol Therapeutics is in the Healthcare sector

    What industry is Cardiol Therapeutics in?

    Cardiol Therapeutics is in the Drug Manufacturers - Specialty & Generic industry

    What country is Cardiol Therapeutics based in?

    Cardiol Therapeutics is headquartered in Canada

    When did Cardiol Therapeutics go public?

    Cardiol Therapeutics's initial public offering (IPO) was on January 15, 2019

    Is Cardiol Therapeutics in the S&P 500?

    No, Cardiol Therapeutics is not included in the S&P 500 index

    Is Cardiol Therapeutics in the NASDAQ 100?

    No, Cardiol Therapeutics is not included in the NASDAQ 100 index

    Is Cardiol Therapeutics in the Dow Jones?

    No, Cardiol Therapeutics is not included in the Dow Jones index

    When was Cardiol Therapeutics's last earnings report?

    Cardiol Therapeutics's most recent earnings report was on May 14, 2025

    When does Cardiol Therapeutics report earnings?

    The next expected earnings date for Cardiol Therapeutics is August 12, 2025
    On this page